Last reviewed · How we verify
NCT07144436
Post-stroke Pain tAN-fMRI
NA trial testing Transcutaneous Auricular Neurostimulation in Post Stroke Pain in 24 participants. Currently enrolling.
30 June 2027
Quick facts
| Lead sponsor | Medical University of South Carolina |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 24 |
| Start date | 8 January 2026 |
| Primary completion | 30 June 2027 |
| Estimated completion | 30 June 2027 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Transcutaneous Auricular Neurostimulation
Conditions studied
- Post Stroke Pain — all drugs for Post Stroke Pain →
Sponsor
Medical University of South Carolina
Who can join
Adults 18 to 80, any sex, with Post Stroke Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to explore whether 4 weeks of at-home transcutaneous auricular neurostimulation (tAN) can reduce chronic pain after a stroke. Investigators will recruit up to 24 participants with chronic post-stroke upper extremity pain. The goal is to determine if there is a pain reduction after ear stimulation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07144436
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Transcutaneous Auricular Neurostimulation
Trials testing the same drug.
- NCT07517172 — Evaluating Noninvasive Brain Stimulation for TMD Pain: A Feasibility Study · NA · not yet recruiting
- NCT06548594 — Out of State - tAN hEDS · NA · completed
- NCT06105541 — Hypermobile Ehlers-Danlos Syndrome - Transcutaneous Auricular Neuromodulation · NA · completed
Other Medical University of South Carolina trials
Trials by the same sponsor.
- NCT06491264 — Multiparameter Optimized tES for Memory in Aging · NA · withdrawn
- NCT07513389 — Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION) · Phase 2 · not yet recruiting
- NCT03101917 — Microtable® Method for Cochlear Implantation Investigational Device Exemption (IDE) · NA · not yet recruiting
- NCT07149207 — Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors · Phase 2 · recruiting
- NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07144436 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University of South Carolina
- Last refreshed: 4 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07144436.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing